News
Zacks Investment Research on MSN6h
ACAD Stock Soars as US Court Rules in Favor of Key Nuplazid PatentAcadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback